Search Results - "Ameen, V. Z."

Dysregulation of the hypothalamic‐pituitary‐adrenal (HPA) axis in irritable bowel syndrome by Chang, L., Sundaresh, S., Elliott, J., Anton, P. A., Baldi, P., Licudine, A., Mayer, M., Vuong, T., Hirano, M., Naliboff, B. D., Ameen, V. Z., Mayer, E. A.

“…Enhanced stress responsiveness has been implicated as a potential mechanism contributing to the pathophysiology of irritable bowel syndrome (IBS), and should…”
Get full text

Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5‐HT3 receptor antagonist: a pilot study by JARCHO, J. M., CHANG, L., BERMAN, S. M., SUYENOBU, B., NALIBOFF, B. D., LIEBERMAN, M. D., AMEEN, V. Z., MANDELKERN, M. A., MAYER, E. A.

“…Aliment Pharmacol Ther 28, 344–352 Summary Background  Symptom improvement in irritable bowel syndrome (IBS) treatment trials varies widely, with only 50–70%…”
Get full text

Long-Term Safety and Efficacy of Alosetron in Women with Severe Diarrhea-Predominant Irritable Bowel Syndrome by CHEY, William D, CHEY, William Y, HEATH, Amy T, DUKES, George E, CARTER, Eric G, NORTHCUTT, Allison, AMEEN, Vanessa Z

“…To assess long-term safety and efficacy of alosetron in women with severe, chronic diarrhea-predominant IBS and in a subset having more frequent urgency (i.e.,…”
Get full text

A Dose-Ranging, Phase II Study of the Efficacy and Safety of Alosetron in Men with Diarrhea-Predominant IBS by LIN CHANG, AMEEN, Vanessa Z, DUKES, George E, MCSORLEY, David J, CARTER, Eric G, MAYER, Emeran A

“…A randomized, double blind, placebo-controlled dose-ranging study was conducted to assess the efficacy of alosetron in men with diarrhea-predominant irritable…”
Get full text

Quantitative fecal carbohydrate excretion in premature infants by Ameen, V Z, Powell, G K

“…Despite relative lactase deficiency and pancreatic insufficiency, premature infants are fed formulas containing 50% lactose plus 50% glucose polymers. We…”
Get full text

Quantitation of fecal carbohydrate excretion in patients with short bowel syndrome by Ameen, V Z, Powell, G K, Jones, L A

“…We performed inpatient balance studies in 11 patients to evaluate the role of carbohydrate malabsorption in the pathogenesis of the diarrhea seen in short…”
Get more information

IS THERE AN INCREASED INFECTION RISK IN INFANTS RECEIVING AN ARACHIDONIC AND DOCOSAHEXAENOIC ACID SUPPLEMENTED FORMULA by Euler, A. R., Ameen, V. Z., Rock, S. S.

Get full text

WHY DON'T INFANTS COMPLETE FORMULA STUDIES? AN EVALUATION OF DISCONTINUATIONS FROM MULTI‐CENTER GROWTH TRIALS by Euler, A. R., Ameen, V. Z., Ledwith, K. E., Rock, S. S.

Get full text

Cholestasis and hypermethioninemia during dietary management of hereditary tyrosinemia type 1 by Ameen, V Z, Powell, G K, Rassin, D K

Get more information

Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5‐HT 3 receptor antagonist: a pilot study by JARCHO, J. M., CHANG, L., BERMAN, S. M., SUYENOBU, B., NALIBOFF, B. D., LIEBERMAN, M. D., AMEEN, V. Z., MANDELKERN, M. A., MAYER, E. A.

“…Aliment Pharmacol Ther   28 , 344–352 Summary Background  Symptom improvement in irritable bowel syndrome (IBS) treatment trials varies widely, with only…”
Get full text

Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3receptor antagonist: a pilot study by JARCHO, JM, Chang, L, Berman, S M, SUYENOBU, B, Naliboff, B D, Lieberman, Md, Ameen, V Z, Mandelkern, Ma, Mayer, E A

“…BackgroundSymptom improvement in irritable bowel syndrome (IBS) treatment trials varies widely, with only 50-70% of patients qualifying as responders. Factors…”
Get full text

Irritable bowel syndrome: toward an understanding of severity by Lembo, Anthony, Ameen, Vanessa Z, Drossman, Douglas A

“…Irritable bowel syndrome (IBS) is a chronic disorder with symptoms that range in severity from mild and intermittent to severe and continuous. Although…”
Get more information

A simple spectrophotometric method for quantitative fecal carbohydrate measurement by Ameen, V Z, Powell, G K

“…A simple quantitative assay was developed for measuring total fecal carbohydrate (CHO) excretion using stools obtained during balance studies performed for…”
Get more information

IS THERE AN INCREASED INFECTION RISK IN INFANTS RECEIVING AN ARACHIDONIC AND DOCOSAHEXAENOIC ACID SUPPLEMENTED FORMULA by Euler, A. R., Ameen, V. Z., Rock, S. S.

Get full text

WHY DON'T INFANTS COMPLETE FORMULA STUDIES? AN EVALUATION OF DISCONTINUATIONS FROM MULTI-CENTER GROWTH TRIALS by Euler, A. R., Ameen, V. Z., Ledwith, K. E., Rock, S. S.

Get full text

Liver transplantation by Rouch, D A, Haag, B W, Gilmore, C, Careskey, J M, Bubb, M P, Sperl, B G, Ameen, V Z, Chua, G T, Polacek, D J, Williams, T M

“…A multidisciplinary approach is necessary in addressing the needs of a patient with end-stage liver disease. The development of the liver transplant program at…”
Get more information

Pharmacodynamics and pharmacokinetics of oral contraceptives co-administered with alosetron (Lotronex) by KOCH, Kevin, CAMPANELLA, Corinne, BAIDOO, Charlotte A, MANZO, Janet A, AMEEN, Vanessa Z, KERSEY, Kathryn E. E

“…The 5-HT3 receptor antagonist alosetron (Lotronex) is indicated for use in women with severe, chronic, diarrhea-predominant irritable bowel syndrome (IBS) who…”
Get full text

Ranitidine (Zantac) syrup versus Ranitidine effervescent tablets (Zantac) EFFERdose) in children: a single-center taste preference study by Ameen, Vanessa Z, Pobiner, Bonnie F, Giguere, Gregory C, Carter, Eric G

“…The histamine H(2) receptor antagonist ranitidine is US FDA-approved for the treatment of gastroesophageal reflux disease and healing of erosive esophagitis in…”
Get full text

PMD28 USING A WEB-PANEL TO AID DEFINITION OF A TARGET PATIENT POPULATION TO ASSIST RISK MANAGEMENT by Eaton, SC, Cook, SF, Andrews, EB, Hollis, KA, Ameen, VZ, Fehnel, SE

Get full text